Cargando…
Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma
The bioactive natural product seriniquinone was discovered as a potential melanoma drug, which was produced by the as-yet-undescribed marine bacterium of the rare genus Serinicoccus. As part of a long-term research program aimed at the discovery of new agents for the treatment of cancer, seriniquino...
Autores principales: | Hirata, Amanda S., La Clair, James J., Jimenez, Paula C., Costa-Lotufo, Leticia Veras, Fenical, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143531/ https://www.ncbi.nlm.nih.gov/pubmed/35621952 http://dx.doi.org/10.3390/md20050301 |
Ejemplares similares
-
Seriniquinones as Therapeutic Leads for Treatment of BRAF and NRAS Mutant Melanomas
por: Hirata, Amanda S., et al.
Publicado: (2021) -
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early‐stage melanoma
por: Ortega‐Martínez, Idoia, et al.
Publicado: (2016) -
Marine drugs for cancer: surfacing biotechnological innovations from the oceans
por: Jimenez, Paula Christine, et al.
Publicado: (2018) -
Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms
por: Vicari, Hugo Passos, et al.
Publicado: (2022) -
The role of Dermcidin isoform-2 in the occurrence and severity of Diabetes
por: Bhattacharya, Suman, et al.
Publicado: (2017)